유영호

All filings by 유영호 on record concern 셀트리온제약, in the capacity of chief executive. The record holds 3 filings, for trades running from 26 March 2024 to 24 March 2026.

Every open-market trade on record is a purchase: 3 purchases worth €113, and no sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.

Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 3 April 2026 with an open-market purchase (€34) in 셀트리온제약. Typically, a trade is published a median of 10 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.